$250 | Single User Price
$500 | Site License Price
$750 | Enterprise License Price

Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 26-07-2017]

Published by Global Data: 26 Jul 2017 | 107890 | In Stock

Introduction

Summary

Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for development. Debiopharm’s products includes decapeptyl, eloxatin, pamorelin, trelstar, moapar and salvacyl among others. The company offer products for the treatment of in vitro fertilization, metastatic colorectal cancer, advanced prostate cancer, precocious puberty, endometriosis, liver cancer, pancreatic cancer, uterine fibroids, severe sexual deviations and other diseases. It also develops drugs for indications in the therapeutic areas of infectious diseases and orphan drugs. The company provides licensing of products to pharmaceutical companies for marketing and sales. Debiopharm is headquartered in Lausanne, Switzerland.

Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 26-07-2017]

  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 5
  • Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
  • Debiopharm International SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
  • Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
  • Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
  • Debiopharm International SA, Medical Devices Deals, 2011 to YTD 2017 10
  • Debiopharm International SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
  • Debiopharm International SA, Pharmaceuticals & Healthcare, Deal Details 14
  • Asset Purchase 14
  • Debiopharm Acquires Antibody Drug Candidate from ImmunoGen 14
  • Debiopharm International Acquires FibroTrap Sample Processing Technology from Spinomix 15
  • Debiopharm Group Acquires Antibiotic Clinical Assets and Technology Platform From Affinium 16
  • Venture Financing 17
  • Spinomix Raises US Million In Series A Financing 17
  • Biocartis Raises US.7 Million In Series D Financing 18
  • Biocartis Secures US Million In Series C Financing Round 19
  • Partnerships 21
  • Debiopharm Partners with Merck and Pfizer 21
  • Debiopharm Enters into Distribution Agreement with Arbor Pharma 22
  • Debiopharm International Enters into Agreement with EORTC 23
  • United Labs Enters into Distribution Agreement with Debiopharm International 24
  • Debiopharm Enters into Agreement with Solid Biosciences 24
  • Atheris Labs Enters Into Agreement With Debiopharm For Debio 0826 Optimization 25
  • Experimental Therapeutics And Debiopharm Enter Into Agreement To Develop Epigenetic Oncology Target 26
  • Debiopharm International And TCG Lifesciences Enter Into Research Agreement To Develop Antibiotics 27
  • Cenix BioScience And Debiopharm Enter Into Agreement To Develop Drug Candidates 28
  • Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 29
  • Debiopharm Group Enters Into Co-Development Agreement With Marina Biotech 30
  • Licensing Agreements 31
  • Debiopharm International Enters into Licensing Agreement with Almac Discovery 31
  • Evotec Enters Into Licensing Agreement With Debiopharm 32
  • Shasun Pharma Enters Into Licensing Agreement With Debiopharm 33
  • Chugai Pharma Enters Into Licensing Agreement With Debiopharm Group For FF284 34
  • Debiopharm Enters Into Licensing Agreement With Ascepion Pharma For Kinase Inhibitor, ASP-08126 35
  • Debiopharm Enters Into Licensing Agreement With Ascenta Therapeutics For AT-406 36
  • Debiopharm Enters Into Licensing Agreement With Yale University For Debio 1036 37
  • Debiopharm Enters Into Option Licensing Agreement With Aurigene Discovery Technologies For Debio 1142 38
  • Debiopharm International SA - Key Competitors 40
  • Key Employees 41
  • Locations And Subsidiaries 42
  • Head Office 42
  • Other Locations & Subsidiaries 42
  • Recent Developments 43
  • Government and Public Interest 43
  • Jul 25, 2017: Debiopharm International Awarded .6 Million Grant from CARB-X to Support Development of Debio 1453 to Fight Drug Resistant Gonorrhea 43
  • Product News 44
  • Oct 25, 2016: Debiopharm International Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450 44
  • Apr 08, 2016: Debiopharm International to present the latest findings on Debio 1450 at ECCMID 45
  • Jan 10, 2016: ImmunoGen Announces Update on IMGN529 and Anticipated 2016 Events in Advance of J.P. Morgan Healthcare Conference 46
  • Clinical Trials 48
  • Jan 10, 2017: Debiopharm International Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients 48
  • Apr 15, 2016: Debiopharm International announces presentation at AACR of non-clinical data relating to its targeted investigational compound Debio 1347/CH5183284, a selective FGFR 1,2,3 inhibitor 49
  • Appendix 50
  • Methodology 50
  • About GlobalData 50
  • Contact Us 50
  • Disclaimer 50

List Of Tables
in Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 26-07-2017]

List of Tables

Debiopharm International SA, Pharmaceuticals & Healthcare, Key Facts 1

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Debiopharm International SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Debiopharm International SA, Deals By Therapy Area, 2011 to YTD 2017 9

Debiopharm International SA, Medical Devices Deals, 2011 to YTD 2017 10

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Debiopharm Acquires Antibody Drug Candidate from ImmunoGen 14

Debiopharm International Acquires FibroTrap Sample Processing Technology from Spinomix 15

Debiopharm Group Acquires Antibiotic Clinical Assets and Technology Platform From Affinium 16

Spinomix Raises US Million In Series A Financing 17

Biocartis Raises US.7 Million In Series D Financing 18

Biocartis Secures US Million In Series C Financing Round 19

Debiopharm Partners with Merck and Pfizer 21

Debiopharm Enters into Distribution Agreement with Arbor Pharma 22

Debiopharm International Enters into Agreement with EORTC 23

United Labs Enters into Distribution Agreement with Debiopharm International 24

Debiopharm Enters into Agreement with Solid Biosciences 24

Atheris Labs Enters Into Agreement With Debiopharm For Debio 0826 Optimization 25

Experimental Therapeutics And Debiopharm Enter Into Agreement To Develop Epigenetic Oncology Target 26

Debiopharm International And TCG Lifesciences Enter Into Research Agreement To Develop Antibiotics 27

Cenix BioScience And Debiopharm Enter Into Agreement To Develop Drug Candidates 28

Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 29

Debiopharm Group Enters Into Co-Development Agreement With Marina Biotech 30

Debiopharm International Enters into Licensing Agreement with Almac Discovery 31

Evotec Enters Into Licensing Agreement With Debiopharm 32

Shasun Pharma Enters Into Licensing Agreement With Debiopharm 33

Chugai Pharma Enters Into Licensing Agreement With Debiopharm Group For FF284 34

Debiopharm Enters Into Licensing Agreement With Ascepion Pharma For Kinase Inhibitor, ASP-08126 35

Debiopharm Enters Into Licensing Agreement With Ascenta Therapeutics For AT-406 36

Debiopharm Enters Into Licensing Agreement With Yale University For Debio 1036 37

Debiopharm Enters Into Option Licensing Agreement With Aurigene Discovery Technologies For Debio 1142 38

Debiopharm International SA, Key Competitors 40

Debiopharm International SA, Key Employees 41

Debiopharm International SA, Subsidiaries 42

List Of Figures, Charts and Diagrams
in Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 26-07-2017]

List of Figures

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Debiopharm International SA, Medical Devices Deals, 2011 to YTD 2017 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

107890 | GDPH114705D

Number of Pages

50

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Debiopharm International SA - Medical Equipment - Deals and Alliances Profile
Summary Debiopharm International SA(Debiopharm), a subsidiary of Debiopharm Group, is a biopharmace...
23 Jan 2017 by Global Data USD $250 More Info
Debiopharm Diagnostics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Debiopharm Diagnostics SA (Debiopharm Diagnostics), formerly Debioinnovation S.A. is a subs...
29 Nov 2016 by Global Data USD $250 More Info
Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Debiopharm International SA(Debiopharm), a subsidiary of Debiopharm Group, is a biopharmace...
25 Nov 2016 by Global Data USD $250 More Info
Debiopharm International SA - Medical Equipment - Deals and Alliances Profile
Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group, is a biopharmac...
04 Nov 2016 by Global Data USD $250 More Info
Debiopharm International SA - Medical Equipment - Deals and Alliances Profile
Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group, is a biopharmac...
21 Jul 2016 by Global Data USD $250 More Info
Debiopharm Diagnostics S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Debiopharm Diagnostics S.A (Debiopharm Diagnostics), a subsidiary of Debiopharm Group, is a...
06 May 2016 by Global Data USD $250 More Info
Debiopharm International S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Debiopharm International S.A. (Debiopharm), a subsidiary of Debiopharm Group is a biopharma...
09 Mar 2016 by Global Data USD $250 More Info
Debiopharm Diagnostics S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Debiopharm Diagnostics S.A (Debiopharm Diagnostics), a subsidiary of Debiopharm Group, is a...
09 Mar 2016 by Global Data USD $250 More Info
Debiopharm International S.A. - Medical Equipment - Deals and Alliances Profile
Summary Debiopharm International S.A. (Debiopharm), a subsidiary of Debiopharm Group is a biopharma...
24 Feb 2016 by Global Data USD $250 More Info
Debiopharm International S.A. - Medical Equipment - Deals and Alliances Profile
Summary Debiopharm International S.A. (Debiopharm), a subsidiary of Debiopharm Group is a biopharma...
16 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Debiopharm International SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 26-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data